Rollover Consent Form - Closing June 15 Reminder

As a reminder, the rollover consent form and process will conclude on June 15, 2021! As part of the transition to the SOR II grant in October 2020, OMNI launched the rollover consent form to allow for an easy transition of SOR I client GPRA information into the SOR II grant period, for those continuing to receive SOR-funded services in the SOR II period.

Timeline:

  • The 8-month no-cost extension of the SOR I grant for follow-up GPRAs will conclude at the end of May 2021 with all SOR I follow-up windows closing after May 31, 2021. As such, the rollover consent form will close two weeks after this on June 15, 2021.

  • After June 15, 2021, you will no longer be able to roll clients from SOR I to SOR II using the rollover consent form and will have to complete a new SOR II intake GPRA interview. Please be sure to complete the rollover form for all SOR I clients continuing to receive SOR II-funded services before June 15, 2021.

With around one month left before the rollover consent form closes, we encourage you to contact SOR I clients that are due for a follow-up and are continuing to receive SOR II-funded services to complete both the SOR I follow-up and a rollover consent form. To help with this, we have put a document in every agency's shared Dropbox folder named "May_Rollover_Check-In", that lists all SOR I clients (i.e., clients that could potentially be rolled over into SOR II if they are continuing to receive SOR II-funded services) along with whether they have a completed rollover consent form or SOR II intake GPRA completed as of Monday, May 10th. This document can help to identify any SOR I clients that are continuing to receive SOR II-funded services and have not yet completed the rollover consent form.

Please reach out to SORSupport@omni.org with any questions or needed support!

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.